These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8545566)

  • 1. [Appearance of anti-DNA antibodies after treatment with interferon in a patient with chronic type C viral hepatitis].
    Ballardini P; Cicognani I; Montanari E; Fabbri F; Ferrari R; Del Noce A
    Riv Eur Sci Med Farmacol; 1995; 17(4):131-2. PubMed ID: 8545566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
    Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
    Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and significance of non-specific anti-organelle antibodies of the liver in chronic viral hepatitis C].
    Borotto E; Lunel F; Valla D; Abuaf N; Perrin M; Bousquet JC; Opolon P; Homberg JC
    Gastroenterol Clin Biol; 1994; 18(10):813-8. PubMed ID: 7875387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.
    Pittau E; Bogliolo A; Tinti A; Mela Q; Ibba G; Salis G; Perpignano G
    Clin Exp Rheumatol; 1997; 15(4):415-9. PubMed ID: 9272304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
    Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
    J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
    Todros L; Saracco G; Durazzo M; Abate ML; Touscoz G; Scaglione L; Verme G; Rizzetto M
    Hepatology; 1995 Nov; 22(5):1374-8. PubMed ID: 7590650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M; Antonelli G; Santantonio T; Giannelli G; Currenti M; Monno L; Turriziani O; Pastore G; Dianzani F
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pemphigus foliaceus after interferon alpha-2a therapy.
    Niizeki H; Inamoto N; Nakamura K; Tsuchimoto K; Hashimoto T; Nishikawa T
    Dermatology; 1994; 189 Suppl 1():129-30. PubMed ID: 8049554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.
    Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S
    Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.
    Shindo M; Di Bisceglie AM; Hoofnagle JH
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1406-8. PubMed ID: 1551549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus].
    Richardet JP; Lons T; Johanet C; Abourached A; Raffoux C; Grimbert S; Sibony M; André C; Trinchet JC; Homberg JC
    Gastroenterol Clin Biol; 1994; 18(10):819-23. PubMed ID: 7875388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY; Oberti F; Foussard C; Calès P
    Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
    Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.